However, it is still unknown whether the nuclear receptor LXR can exert its anti-HCC effects via elevating SOCS3 even though previous studies have shown that LXR suppresses the growth of HCC cells via regulating its downstream target genes such as FOXM1 [11] and ABCA1 [41]. This evidence concerns the gene FOXM1 and hepatocellular carcinoma.